Valsartan and Hydrochlorothiade pills, and preparation method
A technology of tan hydrochlorothiazide and hydrochlorothiazide, which is applied in the field of valsartan hydrochlorothiazide drop pills and its preparation, can solve the problems of unfavorable swallowing difficulties, low bioavailability, unstable quality, etc., and achieve improved bioavailability and bioavailability High degree of dust pollution reduction effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0032] Example 1: In this example, the formulation of valsartan, hydrochlorothiazide and a single matrix is used, and the preparation method in [specific implementation] is operated, the coolant is simethicone oil, dripping pills are made, and the roundness and pill weight are selected Difference, hardness, dissolving time etc. are index, observe the influence of the weight ratio of medicine and single matrix on the product involved in the present invention, test result is shown in Table 1.
[0033] Table 1 Tests of drug and single matrix formulation (all drugs are 1 part)
[0034]
[0035] Note: 1. The coolant is simethicone oil, and the cooling temperature is 3-5°C; the heat preservation temperature of the drug material and the dripper is 85-90°C; the dripping speed is 30-50 grains / minute.
[0036] 2. The above results show that the indicators of Nos. 3, 4, 5, 7, 8, 9, and 10 are better, that is, when the ratio of drug to matrix is 1:2-1:9, it can be dripp...
Embodiment 2
[0037] Example 2: In this example, through the formula of valsartan, hydrochlorothiazide and mixed matrix, operate according to the preparation method in [specific implementation mode], the coolant is simethicone oil, and drop pills are made, and the roundness and pill weight are selected. Difference, hardness, dissolving time etc. are investigation indexes, observe the influence of the weight ratio of medicine and mixed matrix on the product involved in the present invention, test result is shown in Table 2.
[0038] Table 2 Drug and mixed matrix formulation test (1 part of drug)
[0039]
[0040] Note: 1. The coolant is simethicone oil, and the cooling temperature is 8-5°C; the heat preservation temperature of the drug material and the dripper is 85-90°C; the dripping speed is 30-50 grains / minute.
[0041] 2. The above results show that the indicators of No. 2, 3, 5, 6, 8, 9, 11, and 12 tests are all good, that is, when the ratio of drug to matrix is 1:1-1:9, ...
Embodiment 3
[0042] Embodiment 3: In this embodiment, different coolants are selected, and the coolant is simethicone, liquid paraffin, vegetable oil, and polyethylene glycol is selected as a single matrix 6000 , the mixed matrix chooses polyethylene glycol 6000: the formula of poloxamer=1:0.2, operate according to the preparation method in [the specific embodiment], drip dripping pill, select roundness, pill weight difference, hardness, dissolving time etc. as investigation index, observe different The impact of coolant on the products involved in the present invention, the test results are shown in Table 3.
[0043] Table 3 Experiments using different coolants (drug: matrix = 1:3)
[0044]
[0045] Note: 1. The cooling temperature is 8-5°C; the heat preservation and dripper temperature is 85-90°C; the dripping speed is 30-50 capsules / minute.
[0046] 2. The above results show that the indicators of No. 1 and No. 2 tests are better, that is, when the above-mentioned differe...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com